Axonics Modulation Technologies Inc. [NASDAQ: AXNX] closed the trading session at $46.98 on 11/05/20. The day’s price range saw the stock hit a low of $46.35, while the highest price level was $49.17. The company report on November 5, 2020 that Axonics® Reports Third Quarter 2020 Results.
Axonics generated net revenue of $35.2 million in the third quarter ended September 30, 2020.
Over 5,500 patients have been implanted with the Axonics r-SNM System since U.S. commercial launch.
The stocks have a year to date performance of 69.54 percent and weekly performance of -3.87 percent. The stock has been moved at 33.66 percent over the last six months. The stock has performed -3.53 percent around the most recent 30 days and changed 6.60 percent over the most recent 3-months.
If compared to the average trading volume of 529.37K shares, AXNX reached to a volume of 1600790 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Axonics Modulation Technologies Inc. [AXNX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AXNX shares is $55.56 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AXNX stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Axonics Modulation Technologies Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 05, 2020. While these analysts kept the previous recommendation, Guggenheim raised their target price to Buy. The new note on the price target was released on October 23, 2020, representing the official price target for Axonics Modulation Technologies Inc. stock. Previously, the target price had yet another raise to $52, while Robert W. Baird analysts kept a Outperform rating on AXNX stock. On August 07, 2020, analysts increased their price target for AXNX shares from 48 to 57.
The Average True Range (ATR) for Axonics Modulation Technologies Inc. is set at 2.86, with the Price to Sales ratio for AXNX stock in the period of the last 12 months amounting to 36.65. The Price to Book ratio for the last quarter was 5.75, with the Price to Cash per share for the same quarter was set at 6.98.
AXNX stock trade performance evaluation
Axonics Modulation Technologies Inc. [AXNX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.87. With this latest performance, AXNX shares dropped by -3.53% in over the last four-week period, additionally plugging by 33.66% over the last 6 months – not to mention a rise of 102.76% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AXNX stock in for the last two-week period is set at 49.08, with the RSI for the last a single of trading hit 44.84, and the three-weeks RSI is set at 49.86 for Axonics Modulation Technologies Inc. [AXNX]. The present Moving Average for the last 50 days of trading for this stock 45.55, while it was recorded at 48.05 for the last single week of trading, and 37.51 for the last 200 days.
Axonics Modulation Technologies Inc. [AXNX]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Axonics Modulation Technologies Inc. [AXNX] shares currently have an operating margin of -597.68 and a Gross Margin at +53.04. Axonics Modulation Technologies Inc.’s Net Margin is presently recorded at -578.40.
Return on Total Capital for AXNX is now -44.03, given the latest momentum, and Return on Invested Capital for the company is -42.77. Return on Equity for this stock declined to -49.00, with Return on Assets sitting at -40.81. When it comes to the capital structure of this company, Axonics Modulation Technologies Inc. [AXNX] has a Total Debt to Total Equity ratio set at 13.87. Additionally, AXNX Total Debt to Total Capital is recorded at 12.18, with Total Debt to Total Assets ending up at 11.55. Long-Term Debt to Equity for the company is recorded at 13.54, with the Long-Term Debt to Total Capital now at 11.89.
Reflecting on the efficiency of the workforce at the company, Axonics Modulation Technologies Inc. [AXNX] managed to generate an average of -$264,685 per employee. Receivables Turnover for the company is 3.33 with a Total Asset Turnover recorded at a value of 0.07.Axonics Modulation Technologies Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.90 and a Current Ratio set at 10.90.
Earnings per share (EPS) analysis for Axonics Modulation Technologies Inc. [AXNX] stock
With the latest financial reports released by the company, Axonics Modulation Technologies Inc. posted -0.75/share EPS, while the average EPS was predicted by analysts to be reported at -0.72/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -4.20%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AXNX.
Axonics Modulation Technologies Inc. [AXNX]: Insider Ownership positions
There are presently around $1,429 million, in the hands of institutional investors. The top three institutional holders of AXNX stocks are: FMR LLC with ownership of 2,552,217, which is approximately 137.074% of the company’s market cap and around 1.80% of the total institutional ownership; BLACKROCK INC., holding 2,433,419 shares of the stock with an approximate value of $114.32 million in AXNX stocks shares; and RTW INVESTMENTS, LP, currently with $88.47 million in AXNX stock with ownership of nearly 10.196% of the company’s market capitalization.
Positions in Axonics Modulation Technologies Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 96 institutional holders increased their position in Axonics Modulation Technologies Inc. [NASDAQ:AXNX] by around 10,160,145 shares. Additionally, 47 investors decreased positions by around 3,021,833 shares, while 14 investors held positions by with 17,235,064 shares. The mentioned changes placed institutional holdings at 30,417,042 shares, according to the latest SEC report filing. AXNX stock had 37 new institutional investments in for a total of 1,668,641 shares, while 16 institutional investors sold positions of 224,858 shares during the same period.